Azitra (AZTR) Other financing activities (2023 - 2026)
Azitra's (AZTR) quarterly Other financing activities came in at -$1.7 million in Q4 2025, down 9046.53% YoY from $19527.0 in Q4 2024, and down 75071.6% on a QoQ basis from -$2324.0 in Q3 2025.
Azitra (AZTR) Other financing activities (2023 - 2026) Analysis & Trends
Azitra (AZTR) has 3 years of Other financing activities data on file, last reported at -$1.7 million in Q4 2025.
- Quarterly Other financing activities fell 9046.53% year-over-year to -$1.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$1.7 million (up 31.17% YoY) and the FY2022 annual result came in at $1510.0, changed N/A from the prior year.
- Other financing activities slipped to -$1.7 million in Q4 2025, from -$2324.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $6.0 million in Q2 2023 to a low of -$6.0 million in Q3 2023.
- A 3-year average of $0.0 and a median of -$1275.5 in 2024 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 100.44% in 2025, down 9046.53% in 2025.
- Tracing AZTR's Other financing activities over 3 years: stood at -$6.0 million in 2023, then soared by 99.68% to -$19100.0 in 2024, then sank by 9046.53% to -$1.7 million in 2025.
- The last three Other financing activities figures came in at -$1.7 million (Q4 2025), -$2324.0 (Q3 2025), and $1.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Azitra | 2.53 Mn | 2.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,491.00 |
| Jun 30, 2026 | -6,491.00 |
| Mar 31, 2026 | 10.38 Mn |
| Mar 31, 2026 | 10.38 Mn |
| Dec 31, 2025 | -1.75 Mn |
| Dec 31, 2025 | -1.75 Mn |
| Sep 30, 2025 | -2,324.00 |
| Sep 30, 2025 | -2,324.00 |
| Jun 30, 2025 | 1.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | 1.75 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | -19,100.00 |
| Dec 31, 2024 | -19,100.00 |
| Sep 30, 2024 | -4.27 Mn |
| Sep 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | -227.00 |
| Jun 30, 2024 | -227.00 |
| Mar 31, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.29 Mn |